The Current Ratio as of November 2024 (TTM) for InMed Pharmaceuticals Inc. (INM) is 5.07

According to InMed Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.07. This represents a change of -12.16% compared to the average of 5.77 of the last 4 quarters.

InMed Pharmaceuticals Inc. (INM) Historical Current Ratio (quarterly & annually)

How has INM Current Ratio performed in the past?

The mean historical Current Ratio of InMed Pharmaceuticals Inc. over the last ten years is 8.32. The current 5.07 Current Ratio has changed 5.99% with respect to the historical average. Over the past ten years (40 quarters), INM's Current Ratio was at its highest in in the December 2017 quarter at 44.88. The Current Ratio was at its lowest in in the March 2016 quarter at 0.13.

InMed Pharmaceuticals Inc. (INM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of InMed Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InMed Pharmaceuticals Inc. (INM) Average Current Ratio

How has INM Current Ratio performed in the past?

The current Current Ratio of InMed Pharmaceuticals Inc. (INM) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

InMed Pharmaceuticals Inc. (INM) Current Ratio vs. Peers

How is INM’s Current Ratio compared to its peers?

InMed Pharmaceuticals Inc.’s Current Ratio is greater than Quoin Pharmaceuticals, Ltd. (3.02), greater than Allarity Therapeutics, Inc. (2.75), greater than Kiromic BioPharma, Inc. (0.22), less than Virax Biolabs Group Limited (25.94), greater than Biodexa Pharmaceuticals Plc (2.16), greater than SeaStar Medical Holding Corporation (0.54), less than Virios Therapeutics, Inc. (7.27), greater than ZyVersa Therapeutics, Inc. (0.03), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than Revelation Biosciences, Inc. (1.64), greater than Palisade Bio, Inc. (3.31), less than Bright Minds Biosciences Inc. (35.08), greater than Tonix Pharmaceuticals Holding Corp. (3.33), greater than Immix Biopharma, Inc. (3.47), less than Phio Pharmaceuticals Corp. (6.38), greater than 180 Life Sciences Corp. (0.19), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Sigilon Therapeutics, Inc. (2.40), greater than NovaBay Pharmaceuticals, Inc. (1.15), greater than GeoVax Labs, Inc. (4.17),

Build a custom stock screener for InMed Pharmaceuticals Inc. (INM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InMed Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InMed Pharmaceuticals Inc. (INM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InMed Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.